Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia

Leukemia. 2005 Jan;19(1):165-9. doi: 10.1038/sj.leu.2403540.

Authors

B M Frost, E Forestier, G Gustafsson, P Nygren, M Hellebostad, G Jonmundsson, J Kanerva, K Schmiegelow, R Larsson, G Lönnerholm; Nordic Society for Paediatric Haematology and Oncology

PMID: 15526029
DOI: 10.1038/sj.leu.2403540

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Antineoplastic Agents / therapeutic use
Bone Marrow Transplantation
Child
Child, Preschool
Chromosomes, Human, Pair 1*
Chromosomes, Human, Pair 19*
Combined Modality Therapy
Disease-Free Survival
Drug Resistance, Neoplasm / genetics*
Female
Humans
In Situ Hybridization, Fluorescence
Infant
Karyotyping
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery
Reverse Transcriptase Polymerase Chain Reaction
Translocation, Genetic*

Substances

Antineoplastic Agents